L. Sangaralingham
Mayo ClinicPoster Author Of 2 e-Posters
A5920 - Adoption of the Anti-Fibrotic Medications Pirfenidone and Nintedanib Among Commercially-Insured Adults in the United States
Presenter:
Date
05/22/2019
Room
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown
Session Name
D22 - REAL WORLD MEDICATION USE IN PULMONARY DISEASES
Authors
A7393 - Mortality Effect of the Anti-Fibrotics Pirfenidone and Nintedanib in Clinical Practice
Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C35 - HEALTH SERVICES RESEARCH IN COUGH, CF, AND ILD
Authors